Funding for this research was provided by:
Cancer Research UK
Mark Foundation For Cancer Research
Breast Cancer Now
Addenbrookes Charitable Trust
Addenbrooke's Charitable Trust, Cambridge University Hospitals
Received: 13 September 2020
Accepted: 30 November 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: Ethical approval for the Cambridge Personalised Breast Cancer Program was granted by the East of England (Cambridge Central) Health Research Authority (refs 16/EE/0100 and 18/EE/0251).
: Not applicable
: Subsequent to this work, KDH and JCP were employed respectively by Inviata and Illumina, which have interests in cancer diagnostics.